Xiaoyaosan (Tiaogan-Liqi therapy) protects peritoneal macrophages from corticosterone-induced stress by regulating the interaction between glucocorticoid receptor and ABCA1

BACKGROUND: Previous studies have reported that Xiaoyaosan (XYS), Tiaogan-Liqi therapy, has a protective function in depressive disorder, and can regulate body weight and corticosterone (CORT) level. However, little is known about the effect of XYS in treating atherosclerosis. This study aimed to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mingtai, Huang, Ruolan, Fu, Wenjun, Ou, Lijun, Men, Ling, Zhang, Zhong, Yang, Shudong, Liu, Qiang, Luan, Jienan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729347/
https://www.ncbi.nlm.nih.gov/pubmed/33313251
http://dx.doi.org/10.21037/atm-20-6505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729347/
https://www.ncbi.nlm.nih.gov/pubmed/33313251
http://dx.doi.org/10.21037/atm-20-6505

Ejemplares similares